Thalassemia, Beta Clinical Trials
2 recruiting trials for Thalassemia, Beta. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT05799118
Study of the Role of Genetic Modifiers in Hemoglobinopathies
This study will investigate the role of genetic modifiers in hemoglobinopathies through a large-scale, multi-ethnic genome-wide association study (GWAS).
Sponsor: Cyprus Institute of Neurology and GeneticsEnrolling: 3000020 locations
RECRUITINGPhase 2NCT05736419
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive...
Hematopoietic Cell Transplantation/HCT involves receiving healthy blood-forming cells (stem cells) from a donor to replace the diseased or damaged cells in participants' bone...
Sponsor: Memorial Sloan Kettering Cancer CenterEnrolling: 246 locations